Chronopharmacology of Anti-Convulsive Therapy
MetadataShow full item record
CitationRamgopal, Sriram, Sigride Thome-Souza, and Tobias Loddenkemper. 2013. Chronopharmacology of anti-convulsive therapy. Current Neurology and Neuroscience Reports 13(4): 339.
AbstractApproximately one-third of patients with epilepsy continue to have seizures despite antiepileptic therapy. Many seizures occur in diurnal, sleep/wake, circadian, or even monthly patterns. The relationship between biomarkers and state changes is still being investigated, but early results suggest that some of these patterns may be related to endogenous circadian patterns whereas others may be related to wakefulness and sleep or both. Chronotherapy, the application of treatment at times of greatest seizure susceptibility, is a technique that may optimize seizure control in selected patients. It may be used in the form of differential dosing, as preparations designed to deliver sustained or pulsatile drug delivery or in the form of ‘zeitgebers’ that shift endogenous rhythms. Early trials in epilepsy suggest that chronopharmacology may provide improved seizure control compared with conventional treatment in some patients. The present article reviews chronopharmacology in the treatment of epilepsy as well as future treatment avenues.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:10627603
- HMS Scholarly Articles